BCL2L12 and Increased total eosinophil count: The present data revealed that inhibition of Bcl2L12 in Eos was capable of inhibiting Mcd-like inflammation in mice, suggesting that Bcl2L12 may be a novel therapeutic target for heart inflammation related with eosinophilia.